Search

Your search keyword '"Larkin, Catherine"' showing total 364 results

Search Constraints

Start Over You searched for: Author "Larkin, Catherine" Remove constraint Author: "Larkin, Catherine"
364 results on '"Larkin, Catherine"'

Search Results

6. Ex-Tesla Director Denies Any Role in Courting Nissan Investment.

7. Walgreens Sinks After Suspending Dividend to Conserve Cash.

10. Lamb Weston Jumps on Report of Post Mulling Possible Deal.

11. Lamb Weston Jumps on Report That Post Is Exploring Possible Deal.

12. Walgreens Jumps on Report That It's in Talks to Go Private.

13. Steven Madden Targets 40% Cut to China Imports to Avoid Tariffs.

14. Estée Lauder Will Tap Longtime Executive as Next CEO, WSJ Says.

15. Five Takeaways From Tesla's Third-Quarter Earnings Report.

16. Uberrima fides - quo vadis?

18. Multi‐species restoration accelerates recovery of extinguished oyster reefs.

19. Olive Garden Owner Will Buy Chuy's Restaurants for $605 Million.

20. Elon Musk Pursued Women Working at SpaceX for Sex, WSJ Says.

21. Elon Musk Pursued Women Working at SpaceX for Sex, WSJ Reports.

22. Victoria's Secret Jumps as Sales Decline Moderates.

23. Nordstrom Says Founding Family Is Weighing Taking Chain Private.

24. Elon Musk Says Tesla Will Unveil Robotaxi on Aug. 8.

26. Spirit Aero Jumps on Report Boeing Misinstalled Jet Panel.

27. Spirit Aero Jumps on Report That Boeing Misinstalled Jet Panel.

28. Thanksgiving Was Great for Online Shopping, Macy's CEO Says.

29. Lowe's Guidance Hit by Waning Demand for Home Improvement.

30. Road freight summit celebrates its succesful debut in South Africa.

31. Vista Outdoor Cuts Forecast, Will Sell Sporting-Product Unit.

32. Prostate cancer drug wins panel's confidence

33. TARP auditor criticizes Obama administration's push to close auto dealerships

35. WebMD acquiring Hlth Corp

37. FDA says melamine in U.S. formula safe; Chinese milk blocked because of chemical

38. FDA probe threatens stent market; Device makers stop promoting unapproved uses

39. Cardiome heart drug fails to get U.S. approval

40. Birth control pills boost Barr profits

41. Celgene's profit triples on cancer drug sales; Results show growing acceptance of thalidomide-based medications

42. Wyeth shares slip amid delays, competition; Trying to replace $4B in revenue

43. Barr Pharmaceuticals' profit takes a 26% hit

44. BD watches 3rd-quarter gains rise 19%; Revenue boosted by demand for syringe-safety products

45. Barr profit dives 85% on Pliva purchase

46. FDA: Bladder drug needs stronger warning

47. Bristol shares fall on report of Sanofi pullout; Price, legal dispute end merger talks

48. Merck CEO will add board chairman duties

49. Mercury fillings causing concern; FDA advisers warn of possible risk

50. GM, Stellantis, Ford to Be Hit by Walkouts at Three More Plants.

Catalog

Books, media, physical & digital resources